Evidence map›Paper›PMID 32452420›Full record

ArticleVirology2020

Antiviral activity of lycorine against Zika virus in vivo and in vitro.

Huini Chen, Zizhao Lao, Jiangtao Xu, Zhaoxin Li, Haishan Long, Detang Li, Luping Lin, Xiaohong Liu, Liangwen Yu, Weiyong Liu and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Potential Antiviral Compounds fromMolecules (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. An Overview of Zika Virus and Zika Virus Induced Neuropathies.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. RSC advances · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Huini ChenGuangdong Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, 510632, China.
Zizhao LaoMathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Jiangtao XuLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Zhaoxin LiLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Haishan LongLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Detang LiDepartment of Pharmacy, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Luping LinGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.
Xiaohong LiuThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Liangwen YuGuangzhou University of Chinese Medicine, Guangzhou, 510006, China. Electronic address: fisherman@gzucm.edu.cn.
Weiyong LiuDepartment of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: wyliu@hust.edu.cn.
Geng LiGuangdong Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, 510632, China; Laboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. Electronic address: lg@gzucm.edu.cn.
Jianguo WuGuangdong Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, 510632, China. Electronic address: wu9988@vip.sina.com.
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNJinan University · CNGuangzhou Eighth People's Hospital · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence and re-emergence of Zika virus (ZIKV), is a cause for international concern. These highly pathogenic arboviruses represent a serious health burden in tropical and subtropical areas worldwide. Despite these burdens, antiviral therapies do not exist, and inhibitors of ZIKV are therefore urgently needed. To elucidate the anti-ZIKV effect of lycorine, we used reverse transcription-quantitative real-time PCR (qRT-PCR), immunofluorescence,

Indexed as

Amaryllidaceae AlkaloidsAnimalsAntiviral AgentsFemaleHumansMaleMiceMolecular Docking SimulationPhenanthridinesVirus ReplicationZika VirusZika Virus InfectionAmaryllidaceae AlkaloidsAntiviral AgentslycorinePhenanthridinesAG6 miceAlkaloidAntiviralLycorineRdRp inhibitorZIKV

Identifiers

PMID32452420
PMCPMC7194111
OpenAlexW3017165458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.